Werewolf Therapeutics Inc. logo

Werewolf Therapeutics Inc.

HOWL | NASDAQ
Chart Builder DCF Calculator
$0.98
+$0.02 (+1.55%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
-$0.01 (-0.96%)
Pre-market: Sep 22, 2026, 8:59 AM ET

Market Data

Market Cap
$47.62M
Enterprise Value
$25.64M
Beta
0.29
Average Volume
632.34K
Shares Outstanding (Diluted)
48.6M
Shares Change YoY
8.04%
Institutional Ownership
28.81%
Exchange
NASDAQ
ISIN
US95075A1079

Price Performance

Price Change 1M
15.3%
Price Change 3M
170.9%
Price Change 6M
25.6%
Price Change YTD
52.0%
Price Change 1Y
-46.7%
Price Change 3Y
-55.6%
Price Change 5Y
-94.5%
1M CAGR (ann.)
146.8%
1Y CAGR (ann.)
-32.4%
5Y CAGR (ann.)
-43.9%
All-Time CAGR
-40.5%

Valuation

PE Ratio
-1.34
Forward PE
N/A
PEG Ratio
-0.02
Forward PEG
0.04
PS Ratio
2.27
Forward PS
15.40
PB Ratio
2.92
P/FCF Ratio
-1.58
P/Adj. FCF Ratio
-1.40
P/OCF Ratio
-1.58
EV/Sales
1.22
EV/EBIT
-1.00
EV/EBITDA
-1.16
EV/FCF
-0.85
Earnings Yield
-74.5%
FCF Yield
-63.3%
Adj. FCF Yield
-71.3%

Financial Health

Net Cash
$21.99M
Total Debt
$0
Cash & Short-Term Investments
$21.99M
Total Assets
$24.16M
Current Ratio
2.91
Quick Ratio
2.91
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-5.62
Altman Z-Score
-26.38
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
86.4%
Operating Profit Margin
-121.8%
EBITDA Margin
-104.8%
Net Profit Margin
-164.8%
FCF Margin
-143.6%
Adj. FCF Margin
-161.6%
SBC / Revenue
18.1%
SBC Impact (per share)
-12.6%

Returns

Return on Assets
-143.3%
Return on Equity
-167.0%
Return on Invested Capital
-157.0%
Return on Capital Employed
-157.0%
Return on Tangible Assets
-143.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
-5.4%
Revenue CAGR 5Y
7.5%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
25.0%
EPS CAGR 5Y
18.2%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
13.2%
FCF CAGR 5Y
2.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
9
EPS Growth Next 3Y
-11.4%
Revenue Growth Next 3Y
-5.0%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.22
EPS Growth Est (next Q)
-38.9%
Revenue Est (next Q)
$18.31M
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6.50
Price Target Upside
563.3%

Cash Flow

Operating Cash Flow
$-30.15M
Free Cash Flow
$-30.15M
Adj. Free Cash Flow
$-33.94M
FCF Per Share
-$0.62
OCF Per Share
-$0.62
OCF/S Ratio
-143.6%

Income Statement

Revenue
$21M
Gross Profit
$18.15M
Operating Income
$-25.57M
EBITDA
$-22.02M
Net Income
$-34.61M
EPS (Diluted)
-$0.73
Revenue / Employee
$538.46K
Profit / Employee
$-887.51K
Employees
39

© 2026 bestshares.com. All rights reserved.